Vitaliano Spagnuolo

Suggest Changes
Learn More
BACKGROUND Some antihypertensive therapies are limited by dose-dependent adverse effects (AEs). The angiotensin II receptor blocker valsartan has been shown to reduce blood pressure (BP) in a(More)
BACKGROUND The goal of antihypertensive therapy is to provide good blood pressure (BP) control without eliciting adverse effects. OBJECTIVE This study compared the risk-benefit profile of the(More)
OBJECTIVE The aim of this study was to compare the time-effect profiles of a once-daily administration of valsartan and amlodipine, each given alone or in combination with hydrochlorothiazide, in(More)